Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract

Nature Immunology

Volumn 17, Issue 12, 2016, Pages 1373-1380

  Xing, Junji ^a   Weng, Leiyun ^b   Yuan, Bin ^a   Wang, Zhuo ^a   Jia, Li ^a   Jin, Rui ^a   Lu, Hongbo ^b   Li, Xian Chang ^a,c   Liu, Yong Jun ^b,d,e   Zhang, Zhiqiang ^a,c  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b MEDIMMUNE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^e SANOFI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CXCL2 CHEMOKINE; CYTOKINE; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SYNAPTOTAGMIN I; TRIM29 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; NEMO PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; TRIM29 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HAEMOPHILUS INFLUENZAE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLUENZA; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; CELL CULTURE; GENETICS; HAEMOPHILUS INFECTION; IMMUNOLOGY; INFLUENZA A VIRUS; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; ORTHOMYXOVIRUS INFECTION; VIROLOGY;

ANIMALS; CELLS, CULTURED; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; IMMUNITY, INNATE; INFLUENZA A VIRUS; INTERFERON TYPE I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; ORTHOMYXOVIRIDAE INFECTIONS; PROTEOLYSIS; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UBIQUITINATION;

EID: 84989851491     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3580     Document Type: Article

References (50)

1. Guilliams, M. et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210, 1977-1992 (2013).
2. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
3. Vlahos, R. & Bozinovski, S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front. Immunol. 5, 435 (2014).
4. Murray, P.J. & Wynn, T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737 (2011).
5. Kopf, M., Schneider, C. & Nobs, S.P. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16, 36-44 (2015).
6. Hussell, T. & Bell, T.J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81-93 (2014).
7. Westphalen, K. et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506, 503-506 (2014).
8. Ballinger, M.N. et al. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 34, 766-774 (2006).
9. Gonzalez-Juarrero, M. et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J. Leukoc. Biol. 77, 914-922 (2005).
10. Paine, R. III et al. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J. Immunol. 164, 2602-2609 (2000).
11. LeVine, A.M., Reed, J.A., Kurak, K.E., Cianciolo, E. & Whitsett, J.A. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J. Clin. Invest. 103, 563-569 (1999).
12. Murphy, S.L., Xu, J. & Kochanek, K.D. Deaths: final data for 2010. Natl. Vital Stat. Rep. 61, 1-117 (2013).
13. Schneider, C. et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 10, e1004053 (2014).
14. Huang, F.F. et al. GM-CSF in the lung protects against lethal influenza infection. Am. J. Respir. Crit. Care Med. 184, 259-268 (2011).
15. van Riel, D. et al. Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-? induction. PLoS Pathog. 7, e1002099 (2011).
16. Kumagai, Y. et al. Alveolar macrophages are the primary interferon-? producer in pulmonary infection with RNA viruses. Immunity 27, 240-252 (2007).
17. Seo, S.U. et al. Type I interferon signaling regulates Ly6Chi monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog. 7, e1001304 (2011).
18. Everitt, A.R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
19. Bailey, C.C., Huang, I.C., Kam, C. & Farzan, M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 8, e1002909 (2012).
20. Münz, C., Lünemann, J.D., Getts, M.T. & Miller, S.D. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9, 246-258 (2009).
21. Fitzpatrick, A.M., Holguin, F., Teague, W.G. & Brown, L.A. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J. Allergy Clin. Immunol. 121, 1372-1378, 1378 (2008).
22. Lemarie, E. et al. Alveolar macrophage dysfunction in malignant lung tumours. Thorax 39, 448-452 (1984).
23. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005).
24. Jiang, X. & Chen, Z.J. The role of ubiquitylation in immune defence and pathogen evasion. Nat. Rev. Immunol. 12, 35-48 (2011).
25. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005).
26. Seth, R.B., Sun, L., Ea, C.K. & Chen, Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-?B and IRF 3. Cell 122, 669-682 (2005).
27. Xu, L.G. et al. VISA is an adapter protein required for virus-triggered IFN-? signaling. Mol. Cell 19, 727-740 (2005).
28. Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75-86 (2009).
29. Han, X., Du, H. & Massiah, M.A. Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein. J. Mol. Biol. 407, 505-520 (2011).
30. Jin, W., Chang, M. & Sun, S.C. Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance. Cell. Mol. Immunol. 9, 113-122 (2012).
31. Chang, M., Jin, W. & Sun, S.C. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 10, 1089-1095 (2009).
32. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
33. Ting, J.P., Kastner, D.L. & Hoffman, H.M. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6, 183-195 (2006).
34. Wang, R.F., Miyahara, Y. & Wang, H.Y. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 27, 181-189 (2008).
35. Liu, S.Y., Sanchez, D.J. & Cheng, G. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 23, 57-64 (2011).
36. Sadler, A.J. & Williams, B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568 (2008).
37. Taniguchi, T., Ogasawara, K., Takaoka, A. & Tanaka, N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (2001).
38. Hiscott, J., Nguyen, T.L., Arguello, M., Nakhaei, P. & Paz, S. Manipulation of the nuclear factor-?B pathway and the innate immune response by viruses. Oncogene 25, 6844-6867 (2006).
39. Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151 (2003).
40. Fitzgerald, K.A. et al. IKK? and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (2003).
41. Zhao, T. et al. The NEMO adaptor bridges the nuclear factor-?B and interferon regulatory factor signaling pathways. Nat. Immunol. 8, 592-600 (2007).
42. Masuda, Y. et al. TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. Nat. Commun. 6, 7299 (2015).
43. Palmbos, P.L. et al. ATDC/TRIM29 drives invasive bladder cancer formation through miRNA-mediated and epigenetic mechanisms. Cancer Res. 75, 5155-5166 (2015).
44. Zhou, H. et al. Bcl10 activates the NF-?B pathway through ubiquitination of NEMO. Nature 427, 167-171 (2004).
45. Sun, L., Deng, L., Ea, C.K., Xia, Z.P. & Chen, Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301 (2004).
46. Belgnaoui, S.M. et al. Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe 12, 211-222 (2012).
47. Arimoto, K. et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl. Acad. Sci. USA 107, 15856-15861 (2010).
48. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 (2007).
49. Zhang, X., Goncalves, R. & Mosser, D.M. The isolation and characterization of murine macrophages. In. Current Protocols in Immunology Ch. 14, Unit 14 11 (2008).
50. Lupfer, C. et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat. Immunol. 14, 480-488 (2013).